Specific gene markers for TMT (thyroid malignant tumor) and application of specific gene markers
A technology of gene markers and malignant tumors, applied in the field of specific gene markers
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] The present invention uses the WGCNA package in the R software (version 1.63) to implement various functions of weighted correlation network analysis, including network construction, detection modules, topology characteristic calculation, simulation data, visualization and interfaces with external software. All subsequent operations are performed by the WGCNA software package. The clinicopathological data analyzed in the present invention come from 49 widely distributed clinical sites (USA, NCBI expression profile database), a total of 3789 patients, and a total of 4812 thyroid nodule samples (size>1cm) were evaluated. First, a preprocessing check was performed on the collected data of 4812 thyroid nodule samples to exclude samples with excessive missing values and identify abnormal microarray samples. After preprocessing, Principal Component Analysis (PCA) was applied to retest the quality of the pre-screened data, and then hierarchical clustering was performed on th...
Embodiment 2
[0039] Embodiment 2: Verification of characteristic genes in independent samples
[0040] The inventors verified the expression of 24 genes with independent pathological sample data. Through the cBioPortal Cancer Case Genomics Database ( http: / / www.cbioportal.org / ), query the case data set from papillary thyroid carcinoma (TCGA, Cell 2014) (512 tumor patients, 337 controls). As a result, it was found that, compared with the control group, 17 genes among the 24 genes described in Example 1 showed significantly high expression in tumor patients. The 17 genes are: CCND1, CITED1, CLDN1, CLDN16, FBXO2, FN1, FRMD3, GABRB2, KRT19, LIPH, MDK, PROS1, RXRG, SCEL, SLC34A2, STK32A and TENM1. Figure 14 It is a map of aberrantly expressed signature genes in malignant thyroid tumors, composed of Figure 14 It can be seen that the above 17 genes are significantly highly expressed in tumor tissues.
[0041] To expand the sample size of data validation, a total of 915 thyroid cancers wer...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com